506 related articles for article (PubMed ID: 22159170)
21. SEQUENTIAL RETINAL THICKNESS ANALYSIS SHOWS HYDROXYCHLOROQUINE DAMAGE BEFORE OTHER SCREENING TECHNIQUES.
Marmor MF; Durbin M; de Sisternes L; Pham BH
Retin Cases Brief Rep; 2021 May; 15(3):185-196. PubMed ID: 33394957
[TBL] [Abstract][Full Text] [Related]
22. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy.
Marmor MF; Kellner U; Lai TY; Lyons JS; Mieler WF;
Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109
[TBL] [Abstract][Full Text] [Related]
23. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity.
Tsang AC; Ahmadi S; Hamilton J; Gao J; Virgili G; Coupland SG; Gottlieb CC
Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540
[TBL] [Abstract][Full Text] [Related]
24. Fundus autofluorescence and spectral domain optical coherence tomography in early detection of Plaquenil maculopathy.
Kelmenson AT; Brar VS; Murthy RK; Chalam KV
Eur J Ophthalmol; 2010; 20(4):785-8. PubMed ID: 20099229
[TBL] [Abstract][Full Text] [Related]
25. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine.
Chang WH; Katz BJ; Warner JE; Vitale AT; Creel D; Digre KB
Retina; 2008; 28(10):1478-86. PubMed ID: 18997610
[TBL] [Abstract][Full Text] [Related]
26. Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity.
Allahdina AM; Stetson PF; Vitale S; Wong WT; Chew EY; Ferris FL; Sieving PA; Cukras C
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1953-1963. PubMed ID: 29677357
[TBL] [Abstract][Full Text] [Related]
27. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy.
Greenstein VC; Amaro-Quireza L; Abraham ES; Ramachandran R; Tsang SH; Hood DC
Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494
[TBL] [Abstract][Full Text] [Related]
28. Visual Field Sensitivity Prediction Using Optical Coherence Tomography Analysis in Hydroxychloroquine Toxicity.
Jayakar G; De Silva T; Cukras CA
Invest Ophthalmol Vis Sci; 2022 Jan; 63(1):15. PubMed ID: 35015028
[TBL] [Abstract][Full Text] [Related]
29. Value of Microperimetry in Detecting Early Retinal Toxicity of Hydroxychloroquine in Children with Juvenile Systemic Lupus Erythematosus.
Youssef MM; El-Fayoumi D; Sidky MK; Hegazy AI; Marzouk H; Eltanamly RM
Ophthalmologica; 2017; 237(3):180-184. PubMed ID: 28297699
[TBL] [Abstract][Full Text] [Related]
30. [Clinical evaluation of the new screening procedures for hydroxychloroquine retinopathy, according to the American Academy of Ophthalmology guidelines. Prospective study of 184 patients].
Jaumouillé S; Espargillière D; Mouriaux F; Mortemousque B
J Fr Ophtalmol; 2015 May; 38(5):377-87. PubMed ID: 25913441
[TBL] [Abstract][Full Text] [Related]
31. Pericentral retinopathy and racial differences in hydroxychloroquine toxicity.
Melles RB; Marmor MF
Ophthalmology; 2015 Jan; 122(1):110-6. PubMed ID: 25182842
[TBL] [Abstract][Full Text] [Related]
32. LONGITUDINAL CHANGES IN EYES WITH HYDROXYCHLOROQUINE RETINAL TOXICITY.
Allahdina AM; Chen KG; Alvarez JA; Wong WT; Chew EY; Cukras CA
Retina; 2019 Mar; 39(3):473-484. PubMed ID: 30741731
[TBL] [Abstract][Full Text] [Related]
33. Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening.
Kim KE; Ahn SJ; Woo SJ; Park KH; Lee BR; Lee YK; Sung YK
Ophthalmology; 2021 Jan; 128(1):110-119. PubMed ID: 32553941
[TBL] [Abstract][Full Text] [Related]
34. Early morpho-functional changes in patients treated with hydroxychloroquine: a prospective cohort study.
Ruberto G; Bruttini C; Tinelli C; Cavagna L; Bianchi A; Milano G
Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2201-2210. PubMed ID: 30151601
[TBL] [Abstract][Full Text] [Related]
35. Quantitative assessment of outer retinal layers and ellipsoid zone mapping in hydroxychloroquine retinopathy.
Ugwuegbu O; Uchida A; Singh RP; Beven L; Hu M; Kaiser S; Srivastava SK; Ehlers JP
Br J Ophthalmol; 2019 Jan; 103(1):3-7. PubMed ID: 30190364
[TBL] [Abstract][Full Text] [Related]
36. Retinal toxicity found in a patient with systemic lupus erythematosus prior to 5 years of treatment with hydroxychloroquine.
Chiang E; Jampol LM; Fawzi AA
Rheumatology (Oxford); 2014 Nov; 53(11):2001. PubMed ID: 25172940
[No Abstract] [Full Text] [Related]
37. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.
de Sisternes L; Hu J; Rubin DL; Marmor MF
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3415-26. PubMed ID: 26024126
[TBL] [Abstract][Full Text] [Related]
38. Structural and Functional Characterization of the Retinal Effects of Hydroxychloroquine Treatment in Healthy Eyes.
Gil P; Nunes A; Farinha C; Teixeira D; Pires I; Silva R
Ophthalmologica; 2019; 241(4):226-233. PubMed ID: 30654376
[TBL] [Abstract][Full Text] [Related]
39. Retinal toxicity of high-dose hydroxychloroquine in patients with chronic graft-versus-host disease.
Navajas EV; Krema H; Hammoudi DS; Lipton JH; Simpson ER; Boyd S; Easterbrook M
Can J Ophthalmol; 2015 Dec; 50(6):442-50. PubMed ID: 26651304
[TBL] [Abstract][Full Text] [Related]
40. VOLUMETRIC SINGLE-LAYER INNER RETINAL ANALYSIS IN PATIENTS WITH HYDROXYCHLOROQUINE TOXICITY.
Modi YS; Au A; Parikh VS; Ehlers JP; Schachat AP; Singh RP
Retina; 2016 Oct; 36(10):1941-50. PubMed ID: 27258672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
